Table II.
Hepatitis C virus prevalence in population groups at risk of iatrogenic transmission by European Union/European Economic Area (EU/EEA) country
| Haemodialysis recipients |
Recipients of medical/dental procedures |
Recipients of SOHO |
Diabetes patients |
Healthcare workers |
General population |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Prevalence (%) | Ref. | N | Prevalence (%) | Ref. | N | Prevalence (%) | Ref. | N | Prevalence (%) | Ref. | N | Prevalence (%) | Ref. | Prevalence* (%) | |
| France | 3 | 7.7–16.3 | [31], [44], [45] | 1a | 1.4–3.2 | [27] | 2d | 8.2–47.1 | [23], [27] | 3g | 2.1–8.2 | [27] | 0.8 | |||
| Germany | 2 | 3.6–5.2 | [46], [47] | 1b | 11.3 | [48] | 0.4 | |||||||||
| Greece | 2 | 24–29 | [32], [33] | 2e | 2–54.2 | [22], [49] | 2.2 | |||||||||
| Italy | 2 | 15.1–18.8 | [34], [35] | 1c | 8.9 | [50] | 4f | 35.5–95.4 | [21], [51] | 1 | 5.9 | [25] | 2h | 3–6.4 | [39], [40] | 0.4–5.9 |
| Netherlands | 1i | 1.4 | [52] | 0.1 | ||||||||||||
| Poland | 7j | 0.8–1.7 | [28], [29], [30], [38], [53], [54] | 0.7 | ||||||||||||
| Lithuania | 1 | 12.5 | [17] | 1.5 | ||||||||||||
| Romania | 2 | 27.3–39.3 | [18], [19] | 2 | 4.5–7.7 | [55] | 1 | 1.07 | [18] | 3.2 | ||||||
| Spain | 3k | 5.7–53.1 | [20], [56] | 1 | 2.4 | [26] | 0.2–1.1 | |||||||||
| Sweden | 1 | 0.7 | [37] | 0.06 | ||||||||||||
| UK | 1 | 3.3 | [42] | 0.04 | ||||||||||||
| Multi-countryl | 1 | 6.7 | [36] | |||||||||||||
| EU/EEA wide | 17 | 3.3–39.3 | 3 | 8.9–11.3 | 8 | 2–95.4 | 8 | 0.7–9.2 | 11 | 0.8–6.4 | 1.1 | |||||
*Prevalence estimates were derived from a previously published systematic review (Hofstraat et al. Epidemiol Infect 2017; 14:2873–85).
N, number of included studies.
Diabetes patients who had surgery, endoscopy or other invasive procedures.
Persons who received cardiac surgery as infants before 1991.
Family members of hepatitis C virus positive (HCV+) persons who have had dental procedures.
Includes one study in diabetes patients who had blood transfusions (prevalence: 8.2%) and one study in HIV-positive recipients of blood transfusions (prevalence: 47.1%).
Includes one study in cardiac surgery patients who received blood units (prevalence: 2%).
Includes one study in patients with inherited bleeding disorders treated before 1986 (prevalence: 95.4%).
Includes one study in diabetes patients who had blood transfusions (prevalence: 8.2%) and one study in diabetes patients who had medical procedures.
Includes one study on healthcare workers (HCWs) with high risk of exposure (prevalence: 3%).
Exposure prone procedures-performing HCW.
Includes one study in which the sample includes administrative personnel (prevalence: 1.7%).
Includes one study in which the sample was composed of HIV-positive individuals.
The study covered the following countries: Belgium, Italy, France, Germany, Spain, Sweden and UK.